online cancer medicines | Millionpharma

RESIHANCE 40MG DESCRIPTION Resihance 40mg consist of protein kinase inhibitor with a similar structure to sorafenib. It is hoping to act by prohibiting multiple signalling pathways contains in angiogenesis and tumour growth. Resihance 40mg Tablet is commonly given after other chemotherapy have been tried without success. Resihance 40mg which is used as prescription drugs under the supervision of medical practioners. INDICATION: Resihance 40mg is an anticancer drug which is; • Indicated for the treatment of Hepatocellular carcinoma • Indicated for the treatment of Colorectal cancer • Indicated for the treatment of Gastrointestinal stromal tumor. ADME Time to peak plasma is 4 hours and concentration is 2.5mcg/mL for single dose; Bioavailability is 69-83% Regorafenib has protein bounding about 99.5% and M-2 active metabolite is 99.8%; M-5 active metabolite is 99.95% The drug Regorafenib is metabolized by CYP3A4 and UGT1A9 Eliminated via feces 71%; 19% ...

STIVARGA 40MG DESCRIPTION Stivarga 40mg consist of protein kinase inhibitor with a similar structure to sorafenib. It is hoping to act by prohibiting multiple signalling pathways contains in angiogenesis and tumour growth. Stivarga 40mg is commonly given after other chemotherapy have been tried without success. Stivarga 40mg which is used as prescription drugs under the supervision of medical practioners. INDICATION: Stivarga 40mg is an anticancer drug which is; Indicated for the treatment of Hepatocellular carcinoma Indicated for the treatment of Colorectal cancer Indicated for the treatment of Gastrointestinal stromal tumor MECHANISM OF ACTION: Regorafenib consist of systemic therapy which works throughout your body to promote fight certain cancers. Regorafenib belongs to a multikinase inhibitor, may work by stopping some proteins on certain normal and cancer cells. In this way, Regorafenib may inhibit cancers from growing and spreading for a period. Can...

TAGRISSO 80MG DESCRIPTION A Tagrisso 80mg tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib. Tagrisso 80mg is considered as third generation medicine, which is available in tablet form. Tagrisso 80mg is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity. The pharmacological category of Tagrisso 80mg is tyrosine kinase prohibitor. INDICATION: A Tagrisso 80mg tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients. Tagrisso 80mg is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment                                               FIG: Tagrisso 80mg tablet ...

    IMBRUVICA 140MG DESCRIPTION Imbruvica 140mg is a targeted drug aim to destroy the type of cell which has converted into cancerous orends signals which make cancerous cells develop or multiply. In lymphoma, the type of cell which becomes cancerous is called a ‘lymphocyte’ (a type of white blood cell that fights infection). There are different types of lymphocyte which can become cancerous. Imbruvica 140mg attacks B lymphocytes (B cells) and is therefore necessary to treat B-cell lymphomas. Imbruvica 140 mg INDICATION Imbruvica 140mg is an antineoplastic drug which is: • Indicated for the treatment of Chronic lymphocytic leukaemia or small lymphocytic lymphoma • Indicated for the treatment of Mantle cell lymphoma • Indicated for the treatment of Waldenström Macroglobulinemia • Indicated for the treatment of Marginal Zone lymphoma • Indicated for the treatment of Graft vs Host Disease MECHANISM OF ACTION Ibrutinib prohibits the Bruton's tyros...

                                    IMBRUVICA 70MG DESCRIPTION Imbruvica 70mg is a targeted drug aim to destroy the type of cell which has converted into cancerous orends signals which make cancerous cells develop or multiply. In lymphoma, the type of cell which becomes cancerous is called a ‘lymphocyte’ (a type of white blood cell that fights infection). There are different types of lymphocyte which can become cancerous. Imbruvica 70mg attacks B lymphocytes (B cells) and is therefore necessary to treat B-cell lymphomas. INDICATION Imbruvica 70mg capsule is an antineoplastic drug which is: • Indicated for the treatment of Chronic lymphocytic leukaemia or small lymphocytic lymphoma • Indicated for the treatment of Mantle cell lymphoma • Indicated for the treatment of Waldenström Macroglobulinemia • Indicated for the treatment of Marginal Zone lymphoma • Indicated for the...

                                                   TAGRISSO 40MG DESCRIPTION A Tagrisso 40mg tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib. Tagrisso 40mg is considered as third generation medicine, which is available in tablet form. Tagrisso 40mg tablet is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity. The pharmacological category of Tagrisso 40mg is tyrosine kinase prohibitor. INDICATION: A T agrisso 40mg tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients.Tagrisso 40mg is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment. M...

                                    LYNPARZA 50MG DESCRIPTION Olaparib is a generic form of brand name Lynparza 50 mg . Which is required for some types of ovarian cancer that have come back after treatment. It is for people whohave a alter in a gene called BRCA and have had a variety of chemotherapy called platinum Lynparza 50 mg which used asprescription drug which used under the supervision of medical practioners Lynparza 50 mg INDICATION: Lynparza 50 mg tablet is an antitumor medication which is Indicated for the treatment in patients with advanced ovarian cancer Indicated for the treatment in patients with HER2 – negative metastatic breast cancer. MECHANISM OF ACTION: Olaparib belongs to poly (ADP-ribose) polymerase (PARP) enzyme inhibitor, containing PARP1, PARP2, and PARP3. PARP enzymes are included in DNA transcription, cell cycle managing, and DNA repair. Ol...

NUBLEXA 40MG DESCRIPTION:           Nublexa 40mg consist of protein kinase inhibitor with a similar structure to sorafenib. It is hoping to act by prohibiting multiple signalling pathways contains in angiogenesis and tumour growth. Nublexa 40mg is commonly given after other chemotherapy have been tried without success. Nublexa 40mg tablet which is used asprescription drugs under the supervision of medical practioners. Nublexa 40 mg USAGE: Nublexa 40mg is an anticancer drug which is; Indicated for the treatment of Hepatocellular carcinoma Indicated for the treatment of Colorectal cancer Indicated for the treatment of Gastrointestinal stromal tumor MECHANISM OF ACTION:                Regorafenib consist of systemic therapy which works throughout your body to promote fight certain cancers. Regorafenib belongs to a multikinase inhibitor, may work by stopping some proteins on certain no...